Sayed Saleh sayed Hassan
About me
Dr. Sayed Esa is a researcher specializing in pharmaceutical sciences, nanomedicine, enzymology, and computational drug discovery. His research focuses on evaluating novel therapeutic formulations using in vitro cytotoxicity, antioxidant, enzymatic, apoptosis, and antimicrobial assays, alongside molecular docking and virtual screening. His work aims to develop innovative nanotechnology-based therapies for chronic diseases, diabetic complications, infectious diseases, and cancer.
Dr. Sayed Esa is a researcher with expertise in evaluating the biological performance of novel pharmaceutical formulations through in vitro cytotoxicity, antioxidant, apoptosis, antimicrobial, and enzymology assays. His research includes the investigation of enzyme activity, enzyme kinetics, oxidative stress biomarkers, and biochemical pathways involved in disease progression and therapeutic response, with particular emphasis on antioxidant and detoxification enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), and related biomarkers. He also integrates computational drug discovery approaches, including molecular docking and virtual screening, to identify and optimize potential therapeutic candidates. His research aims to bridge pharmaceutical technology, enzymology, nanomedicine, and translational biomedical science to develop safe and effective therapeutic strategies for chronic diseases, diabetic complications, infectious diseases, and cancer.